Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

doi:10.1186/s12885-023-10521-1

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

8 Downloads (Pure)

Abstract

Correction: Trials 23, 913 (2022)

https://doi.org/10.1186/s13063-022-06829-

Original language	English
Article number	70
Pages (from-to)	1-1
Journal	BMC Cancer
Volume	23
Issue number	1
DOIs	https://doi.org/10.1186/s12885-023-10521-1
Publication status	Published - 20 Jan 2023

Access to Document

10.1186/s12885-023-10521-1Licence: CC BY

s12885-023-10521-1Final published version, 651 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)'. Together they form a unique fingerprint.

Cite this

(2023). Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). BMC Cancer, 23(1), 1-1. Article 70. https://doi.org/10.1186/s12885-023-10521-1

@article{00aaf5b6d9024b98b7b8e193a748f097,

title = "Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)",

abstract = "Correction: Trials 23, 913 (2022)https://doi.org/10.1186/s13063-022-06829-",

author = "D. Doppenberg and Besselink, {M. G.} and {van Eijck}, {C. H.J.} and Intven, {M. P.W.} and {Groot Koerkamp}, B. and G. Kazemier and {van Laarhoven}, {H. W.M.} and M. Meijerink and Molenaar, {I. Q.} and Nuyttens, {J. J.M.E.} and {van Os}, R. and {van Santvoort}, {H. C.} and {van Tienhoven}, G. and Verkooijen, {H. M.} and E. Versteijne and Wilmink, {J. W.} and Lagerwaard, {F. J.} and Bruynzeel, {A. M.E.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2023",

month = jan,

day = "20",

doi = "10.1186/s12885-023-10521-1",

language = "English",

volume = "23",

pages = "1--1",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central",

number = "1",

}

2023, 'Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)', BMC Cancer, vol. 23, no. 1, 70, pp. 1-1. https://doi.org/10.1186/s12885-023-10521-1

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). /.
In: BMC Cancer, Vol. 23, No. 1, 70, 20.01.2023, p. 1-1.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction

T2 - Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

AU - Doppenberg, D.

AU - Besselink, M. G.

AU - van Eijck, C. H.J.

AU - Intven, M. P.W.

AU - Groot Koerkamp, B.

AU - Kazemier, G.

AU - van Laarhoven, H. W.M.

AU - Meijerink, M.

AU - Molenaar, I. Q.

AU - Nuyttens, J. J.M.E.

AU - van Os, R.

AU - van Santvoort, H. C.

AU - van Tienhoven, G.

AU - Verkooijen, H. M.

AU - Versteijne, E.

AU - Wilmink, J. W.

AU - Lagerwaard, F. J.

AU - Bruynzeel, A. M.E.

PY - 2023/1/20

Y1 - 2023/1/20

N2 - Correction: Trials 23, 913 (2022)https://doi.org/10.1186/s13063-022-06829-

AB - Correction: Trials 23, 913 (2022)https://doi.org/10.1186/s13063-022-06829-

UR - http://www.scopus.com/inward/record.url?scp=85146816113&partnerID=8YFLogxK

U2 - 10.1186/s12885-023-10521-1

DO - 10.1186/s12885-023-10521-1

M3 - Comment/Letter to the editor

C2 - 36670370

AN - SCOPUS:85146816113

SN - 1471-2407

VL - 23

SP - 1

EP - 1

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 70

ER -

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). BMC Cancer. 2023 Jan 20;23(1):1-1. 70. doi: 10.1186/s12885-023-10521-1

Abstract

Access to Document

Other files and links

Fingerprint

Cite this